- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/02 - Bacterial antigens
Patent holdings for IPC class A61K 39/02
Total number of patents in this class: 3641
10-year publication summary
|
247
|
304
|
244
|
264
|
259
|
212
|
172
|
154
|
148
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1696 |
115 |
| Intervet Inc. | 872 |
79 |
| Intervet International B.V. | 1283 |
67 |
| Zoetis Services LLC | 1553 |
56 |
| The Regents of the University of California | 19517 |
52 |
| Boehringer Ingelheim Animal Health USA Inc. | 495 |
42 |
| The Trustees of the University of Pennsylvania | 4260 |
38 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2617 |
37 |
| University of Maryland, Baltimore | 1002 |
30 |
| Advaxis, Inc. | 71 |
25 |
| Valneva Austria GmbH | 113 |
25 |
| Novartis AG | 11254 |
24 |
| The United States of America as represented by the Secretary of the Navy | 2720 |
24 |
| Institut Pasteur de Lille | 166 |
24 |
| Virginia Commonwealth University | 611 |
24 |
| President and Fellows of Harvard College | 5913 |
23 |
| National Research Council of Canada | 1569 |
23 |
| University of Florida Research Foundation, Inc. | 3958 |
21 |
| Children's Medical Center Corporation | 1826 |
21 |
| Boehringer Ingelheim Vetmedica GmbH | 1289 |
20 |
| Other owners | 2871 |